Haofeng Lu

2.8k total citations · 1 hit paper
9 papers, 205 citations indexed

About

Haofeng Lu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Haofeng Lu has authored 9 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Cancer Research. Recurrent topics in Haofeng Lu's work include RNA modifications and cancer (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Haofeng Lu is often cited by papers focused on RNA modifications and cancer (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Haofeng Lu collaborates with scholars based in China. Haofeng Lu's co-authors include Mi Li, Tiequan Zhang, Peng Xia, Hao Zhang, Zhonglin Zhang, Kequan Xu, Jie Liu, Weijie Ma, Zhang Chen and Xi Chen and has published in prestigious journals such as Medicine, World Journal of Gastroenterology and BMC Cancer.

In The Last Decade

Haofeng Lu

7 papers receiving 203 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression

2023 99 citations Peng Xia, Hao Zhang et al. Cancer Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haofeng Lu China	5	127	94	53	34	29	9	205
Léa Meunier France	4	142 1.1×	90 1.0×	90 1.7×	31 0.9×	39 1.3×	6	245
Mengxian Tu China	6	116 0.9×	84 0.9×	37 0.7×	45 1.3×	42 1.4×	8	225
Juan L López-Cánovas Spain	9	182 1.4×	81 0.9×	22 0.4×	36 1.1×	13 0.4×	13	250
Rongdang Fu China	8	221 1.7×	176 1.9×	56 1.1×	21 0.6×	55 1.9×	16	328
Timothy A. Dinh United States	9	205 1.6×	133 1.4×	81 1.5×	27 0.8×	53 1.8×	15	307
Emiliano Pasquini Italy	4	141 1.1×	41 0.4×	53 1.0×	38 1.1×	45 1.6×	6	237
Diannan Xu China	7	110 0.9×	81 0.9×	43 0.8×	58 1.7×	19 0.7×	8	174
Bérengère Ouine France	5	120 0.9×	56 0.6×	51 1.0×	18 0.5×	14 0.5×	7	193
Zuojun Zhen China	7	50 0.4×	36 0.4×	55 1.0×	32 0.9×	45 1.6×	16	158
Misti McCain United Kingdom	6	101 0.8×	54 0.6×	38 0.7×	47 1.4×	11 0.4×	9	205

Countries citing papers authored by Haofeng Lu

Since Specialization

Citations

This map shows the geographic impact of Haofeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haofeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haofeng Lu more than expected).

Fields of papers citing papers by Haofeng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haofeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haofeng Lu. The network helps show where Haofeng Lu may publish in the future.

Co-authorship network of co-authors of Haofeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Haofeng Lu. A scholar is included among the top collaborators of Haofeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haofeng Lu. Haofeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Hu, Jianda, et al.. (2025). Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving lenvatinib: a retrospective, multicenter cohort study. BMC Cancer. 25(1). 1137–1137.

2.

Chen, Weibo, Wenbo Zou, Meng Zhang, et al.. (2025). Robotic hepatobiliary and pancreatic surgery using the Chinese domestic robotic platforms: a multicenter retrospective cohort study on prospectively collected data. International Journal of Surgery. 112(3). 7425–7434.

3.

Xia, Peng, Hao Zhang, Haofeng Lu, et al.. (2023). METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Cancer Communications. 43(3). 338–364. 99 indexed citations breakdown →

4.

Lu, Haofeng, et al.. (2022). Expression of PD-L1 and PD-1 in stage T4 rectal cancer tissues and surrounding metastatic lymph nodes and correlation with prognosis. Cellular and Molecular Biology. 68(8). 74–78. 3 indexed citations

5.

Liu, Xiaohong, et al.. (2021). A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients. Medicine. 100(29). e26491–e26491. 4 indexed citations

6.

Zhang, Tiequan, Mi Li, Haofeng Lu, & Tao Peng. (2021). Up-Regulation of circEIF6 Contributes to Pancreatic Cancer Development Through Targeting miR-557/SLC7A11/PI3K/AKT Signaling. Cancer Management and Research. Volume 13. 247–258. 31 indexed citations

7.

Lu, Haofeng, et al.. (2020). Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 87(2). 217–228. 16 indexed citations

8.

Wang, Guangzhi, et al.. (2020). Haemorrhagic retroperitoneal paraganglioma initially manifesting as acute abdomen: a rare case report and literature review. BMC Surgery. 20(1). 304–304. 4 indexed citations

9.

Jiang, Jinghang, Zhe Guo, Haofeng Lu, et al.. (2015). Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis. World Journal of Gastroenterology. 21(15). 4627–4634. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact